ORAMED PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
ORAMED PHARMACEUTICALS INC. (ORMP) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $122.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-26
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $122.00K.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was -$878.00K, a 220.11% decline from fiscal 2023.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $731.00K, a 36.55% decline from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $1.15M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 4 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 125 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 137 month |
|---|---|---|---|---|---|
| 2025-12-31 | $122.00K 10-K · filed 2026-03-26 | ||||
| 2024-12-31 | -$878.00K 10-K · filed 2025-03-27 | ||||
| 2023-12-31 | $731.00K 10-K · filed 2025-03-27 | ||||
| 2022-12-31 | $1.15M 10-K · filed 2023-03-06 | ||||
| 2021-12-31 | $249.00K 10-K · filed 2023-03-06 | ||||
| 2021-08-31 | $310.00K 10-K · filed 2023-03-06 | ||||
| 2020-08-31 | $135.00K 10-K · filed 2021-11-24 | ||||
| 2019-08-31 | $86.00K 10-K · filed 2020-11-24 | ||||
| 2018-08-31 | $112.00K 10-K · filed 2019-11-27 | ||||
| 2017-08-31 | $327.00K 10-K · filed 2019-11-27 | ||||
| 2016-08-31 | $167.00K 10-K · filed 2018-11-28 | ||||
| 2015-08-31 | $422.00K 10-K · filed 2017-11-29 | ||||
| 2014-08-31 | $480.00K 10-K · filed 2016-11-25 | ||||
| 2013-08-31 | $374.00K 10-K · filed 2015-11-25 | $374.06K 10-K · filed 2013-11-27 | $2.62M 10-K · filed 2013-11-27 | ||
| 2012-08-31 | $120.00K 10-K · filed 2014-11-14 | $120.16K 10-K · filed 2012-12-12 | $2.24M 10-K · filed 2012-12-12 | ||
| 2011-08-31 | $481.12K 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |